The UK government plans to turbocharge the life sciences sector using policy levers to enhance research and development, innovation hubs, and private fundraising.
In this piece, Michael Bloch explores how refinements to...more
3/27/2025
/ Capital Markets ,
Healthcare ,
International Labor Laws ,
Investment ,
Investment Management ,
Legislative Agendas ,
Life Sciences ,
New Legislation ,
Patent Litigation ,
Pensions ,
Pharmaceutical Industry ,
Popular ,
Private Equity ,
UK ,
Universities ,
Venture Capital
This publication is one of several Allen & Overy publications on the FCA’s Consultation Paper (CP23/31), setting out its detailed proposals for listing rules reforms as part of its Primary Markets Effectiveness...more
Today the FCA has published its Consultation Paper (CP23/31) setting out its detailed proposals for listing rules reforms as part of its Primary Markets Effectiveness Review. This is the first of two consultations on the...more
This tech-driven approach is not just an option; it's a necessity. Michael Bloch, Partner at A&O, explains, "IPOs are incredibly complex, but we are exploring ways to make them less painful for everyone involved through the...more
10/20/2023
/ Acquisitions ,
Capital Markets ,
Corporate Governance ,
Disclosure Requirements ,
EU ,
Initial Public Offering (IPO) ,
Investment ,
Investors ,
London Stock Exchange ,
Mergers ,
Private Equity ,
Required Documentation ,
UK